TCT 481: Improvement of Tricuspid Regurgitation by Interventional Annuloplasty - One-Year Outcomes of a Single-Center Registry

Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:

• Grant Support/Research Contract - Boston Scientific Corporation; Edwards Lifesciences; Abbott
• Consultant Fee/Honoraria/Speaker’s Bureau - Bayer AG; Cardiac Dimensions